Brain scans reveal secrets of migraine Drug's inner workings
NCT ID NCT04271202
First seen Jan 26, 2026 · Last updated May 21, 2026 · Updated 13 times
Summary
This study looked at how galcanezumab, a newer migraine prevention drug, affects the brain in people with chronic migraine. Researchers used MRI scans to measure changes in brain structure over time. The goal was to learn whether the drug works inside or outside the brain, helping to improve future treatments. 64 adults with chronic migraine took part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MIGRAINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pain Clinic at Beth Israel Deaconess Medical Center
Brookline, Massachusetts, 02445, United States
Conditions
Explore the condition pages connected to this study.